The Argenta website uses cookies to store information on your computer, to improve our website. One of the cookies we use is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies we use and how to delete them, see our privacy notice.

I accept cookies from this site
 

In this section...

Early Safety Assessment

Argenta’s models can provide information on the potential safety of compounds under pre-clinical investigation. Such information is essential in understanding the suitability of a particular compound as a Candidate Drug. Early assessment empowers drug discovery organisations with key data, prior to committing time and resource on expensive pre-clinical development.

For more information on our early safety assessment capabilities please contact us.


Print to HTML

Innovation. Expertise. Delivered